Items tagged with Access
Survivors and activists demand increased action against TB (post)
While the almost 70% price reduction in important tuberculosis prevention drug Rifapentine for 100 countries with significant TB epidemics is a breakthrough, the high cost of newer drugs remains a barrier.
Heated debate on access to TB drugs at global meet (post)
A panel discussion on partnership to treat TB at the 50th Union World Conference on Lung Health ended in a heated debate over unavailability and unaffordability of improved TB drugs in India.
Six highlights from a week of important TB developments (post)
Researchers, policymakers and activists gathered in Hyderabad, India for the 50th Union World Conference on Lung Health, held on 30 October – 2 November 2019.
The Stop TB Partnership's Global Drug Facility Pediatric Drug-Resistant TB initiative (post)
The Stop TB Partnership’s Global Drug Facility officially launched the Pediatric Drug-Resistant TB (DR-TB) Initiative aimed at ending the disease by increasing the access of child-friendly DR-TB treatments to children who need them, wherever they are in the world.
Zero-ing in on eliminating catastrophic costs for TB: can active case finding help? (post)
TB is the deadliest infectious disease worldwide. The disease can also cause a heavy financial burden for families, particularly in low- and middle-income countries. In a recent article in Infectious Diseases of Poverty authors Noemia Siqueira and Kritika Dixit investigated whether active case finding can reduce patient incurred costs for TB in Nepal.
On Universal Health Coverage Day, The Union calls for TB diagnosis, treatment and prevention for all (post)
On Universal Health Coverage (UHC) Day, 12 December 2019, The Union joins advocates worldwide to demand strong, equitable health systems for all, regardless of their income or location.
Webinar: Advocacy for access to DR-TB treatment - webinar materials now available online (post)
The TB Europe Coalition conducted a webinar on 13 November 2019 on advocating for the new guidelines on drug-resistant TB (DR-TB) treatment. The webinar materials are now available online.
Preventing TB: a big drug price cut paves the way for global scale-up (post)
Lengthy negotiations ended in good news recently when the price of rifapentine, a lifesaving antibiotic, was marked down by 66% by its manufacturer Sanofi. When combined with another antibiotic (isoniazid), rifapentine can prevent tuberculosis (TB) disease. The move was announced at the Union World Conference on Lung Health in October 2019.
Nepal: TB patients continue to face medication barrier (post)
TB patients continue to experience barriers in access, diagnosis and completion of treatment.
Stop TB Partnership’s Global Drug Facility Pediatric DR-TB Initiative short film (post)
The Stop TB Partnership’s Global Drug Facility (GDF) announced the submission of a short film about the Pediatric Drug-Resistant TB (DR-TB) Initiative into the Webby Awards.
Page 40 of 83 · Total posts: 0
←First 39 40 41 Last→